Search: “novavax”
Novavax’s Vaccine Candidate Shows Nearly 90% Efficacy in UK
Novavax, a vaccine development company headquartered in Gaithersburg, says its COVID-19 vaccine candidate showed 89.3% efficacy in UK clinical trials. The UK study enrolled more than 15,000 volunteers, according to… Read More
Novavax Busca Voluntarios para Ensayos de Vacunas COVID-19
Novavax, una empresa de desarrollo de vacunas con sede en Gaithersburg, ha iniciado la Fase 3 para su candidata a vacuna COVID-19. Es el quinto candidato en alcanzar la Fase… Read More
Novavax Looking for Volunteers for COVID-19 Vaccine Trials
Novavax, a vaccine development company headquartered in Gaithersburg, has initiated Phase 3 for its COVID-19 vaccine candidate. It is the fifth candidate to reach Phase 3 in the U.S., after… Read More
Novavax Ingresa a la Fase 3 de Pruebas para la Vacuna COVID-19
Novavax, que tiene su sede en Gaithersburg e instalaciones en Rockville, anunció que ha pasado a la Fase 3 de su ensayo de eficacia para su vacuna COVID-19. Prevent-19 está… Read More
Close to ‘Finish Line,’ Novavax Enters Phase 3 Trials for COVID-19 Vaccine
Novavax, which is headquartered in Gaithersburg and has facilities in Rockville, announced it has moved into Phase 3 of its efficacy trial for its COVID-19 vaccine. Prevent-19 is designed to… Read More
Novavax Releases $1.6 Billion Government Contract for COVID-19 Vaccine
Novavax, a vaccine development company in Gaithersburg, Md., released details for a $1.6 billion government contract for a COVID-19 vaccine on Nov. 11, according to NPR. The contract is part… Read More
Hogan Tours Vaccine Development Company Novavax in Gaithersburg
On Thursday, Gov. Larry Hogan toured Novavax, a Gaithersburg company that is developing a COVID-19 vaccine. The vaccine candidate is currently in Phase 2 of clinical trials in the U.S.,… Read More
Novavax Llega a un Acuerdo con Canadá para Suministrar la Vacuna COVID-19
La empresa de biotecnología de Gaithersburg, Novavax, anunció el lunes que llegó a un acuerdo para administrar a Canadá hasta 76 millones de dosis de la vacuna COVID-19 de Novavax.… Read More
Novavax Reaches Agreement With Canada to Supply COVID-19 Vaccine
Gaithersburg biotechnology company Novavax announced Monday that it has reached an agreement in principle to give Canada up to 76 million doses of Novavax’s COVID-19 vaccine. In a statement the… Read More
Gaithersburg-Based Novavax Included in New York Times’ Coronavirus Vaccine Tracker
The New York Times has published a coronavirus vaccine tracker that shows the progress of the more than 165 vaccines in development, and the 30 that are in human trials.… Read More
Novavax’s COVID-19 Vaccine Generates Positive Results in Phase 1 Trial
The Gaithersburg-based biotechnology company Novavax reported positive results Tuesday in phase 1 of its clinical trial for a potential COVID-19 vaccine. Promising news #MadeInMontgomery. https://t.co/rC2H7EkGQf — Montgomery Council (@MoCoCouncilMD) August… Read More
Fujifilm Joins Novavax’s Production List for COVID-19 Vaccine
The Tokyo-based Fujifilm Diosynth Biotechnologies joined other companies Monday in helping Gaithersburg’s Novavax produce and distribute the first batch of a potential COVID-19 vaccine to be used in clinical trials. … Read More